Google, Facebook, Apple launch 'Breakthrough Prize in Life Sciences'

Updated on 21 February 2013

The award recognizes excellence in research that is aimed at curing intractable diseases and extending human life. The prize will be administered by the Breakthrough Prize in Life Sciences Foundation whose management comprises of Google founder Sergey Brin and his wife Anne Wojcicki, Facebook founder Mark Zuckerberg and his wife Priscilla Chan, Apple and Genentech chairman Arthur Levinson and Russian entrepreneur Yuri Milner

google-co-founder-sergey-brin-l-and-facebook-co-founder-mark-zuckerberg-r-launch-the-breakthrough-prize-in-life-sciences-prize-along-with-their-spouses-and-chairman-of-apple-arthur-levinson-and-russian-entr

Google co-founder Sergey Brin (L) and Facebook co-founder Mark Zuckerberg (R) launch the Breakthrough Prize in Life Sciences prize along with their spouses and chairman of Apple, Arthur Levinson, and Russian entrepreneur Yuri Milner

Singapore: Mr Sergey Brin (computer scientist and co-founder of Google), Ms Anne Wojcicki (American biologist, co-founder of 23andMe, and wife of Mr Brin), Mr Mark Zuckerberg (co-founder of Facebook), Ms Priscilla Chan (wife of Mr Zuckerberg), Mr Arthur Levinson (chairman of Genentech and Apple), and Mr Yuri Milner (Russian entrepreneur and venture capitalist) announced the launch of the 'Breakthrough Prize in Life Sciences'.

The award recognizes excellence in research that is aimed at curing intractable diseases and extending human life. The prize will be administered by the Breakthrough Prize in Life Sciences Foundation, a not-for-profit corporation dedicated to advancing breakthrough research, celebrating scientists and generating excitement about the pursuit of science as a career.

The first 11 recipients of the Breakthrough Prize have been decided as Dr Cornelia I Bargmann (for the genetics of neural circuits and behavior, and synaptic guidepost molecules), Dr David Botstein (for linkage mapping of Mendelian disease in humans using DNA polymorphisms), Dr Lewis C Cantley (for the discovery of PI 3-Kinase and its role in cancer metabolism), Dr Hans Clevers (for describing the role of Wnt signaling in tissue stem cells and cancer), Dr Napoleone Ferrara (for discoveries in the mechanisms of angiogenesis that led to therapies for cancer and eye diseases).

The other recipients include, Dr Titia de Lange (for research on telomeres, illuminating how they protect chromosome ends and their role in genome instability in cancer), Dr Eric S Lander (for the discovery of general principles for identifying human disease genes), Dr Charles L Sawyers (for cancer genes and targeted therapy), Mr Bert Vogelstein (for cancer genomics and tumor suppressor genes), Dr Robert A Weinberg (for characterization of human cancer genes), Dr Shinya Yamanaka (Nobel Laureate known for his work on induced pluripotent stem cells). All prize winners have agreed to serve on the Selection Committee of the Foundation to choose recipients of future prizes.

One of the distinguishing characteristics of the prize will be that anyone will be able to nominate a candidate online for consideration. Also, the prize can be shared between any number of deserving scientists and can be received more than once. In addition, there are no age restrictions for nominees. All Breakthrough Prize recipients will be invited to present public talks targeting a general audience. These lectures, together with supporting materials, will be made available to the public, allowing everyone to keep abreast of the latest developments in life sciences, guided by contemporary masters of the field.

 

Previous 1

Leave a Reply

Post Comment

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X